1-2 June 2010
London, UK
Originally planned for February 2010, the 2nd European Forum was moved to 1st to 2nd June 2010 to await the release of EudraCT Version 8. Dedicated to providing accurate and up-to-date coverage of the increasingly global regulatory framework, this program is a must-attend for anyone involved in trial registration and results disclosure. Don’t miss your opportunity to hear industry leaders, regulators and other stakeholders discuss what it takes to remain compliant.
Featured sessions include:
Analyse the Unique Requirements of the German Clinical Trial Register
Gabriele Dreier, MD, German WHO-Primary Registry DRKS, Head of Clinical Trial Registries, ZKS – Clinical Trials Center, University Medical Center Freiburg
Explore the Requirements of the SUKL Clinical Trial Registry
Tomáš Boráń, MD, Clinical Trial Unit, State Institute for Drug Control, Czech Republic
Clinical Trial Disclosure Developments in Latin America
John C McKenney, President, SEC Associates, Inc.
Contact Info:
Programme Manager, Kevin Palmaccio
Phone: +1 339 298 2101
Email: kevin.palmaccio@cbinet.com
The Center for Business Intelligence
600 Unicorn Park Drive
Woburn, MA01801
Main phone: +1 800 817 8601
www.cbinet.com/ctrrd |
